Notes for Today: March 6, 2010
Back when I started my blog, I would have entries that were simply lists of links that I'd come across and thought worth sharing or brief events during the day. Never mind "sharing with whom." The impetus to share, presuming some sort of tenuous permanence seems like a decent rationale for blogging.
Saturday's my day to work myself into a little frenzy about savings etc, so I listened to
Marketplace Money and called TiVo to follow up on cancelling my subscription from a long while back and that an acceptable refund was issued. I still sort of want one of the new super cool HD
TiVo Premiers because Comcast's DVR is just awful.
Later, I watch the latest episode of Caprica and lamented (privately) that the Facebook fan page for Caprica showed the closing climactic scene of Friday's episode as a preview last week, pretty much making episode 6 literally anticlimactic. I also looked up the word
apotheosis that Sister Clarisse likes to say.
I read a recent first hand report of someone who attended Singularity U's executive conference and got to thinking about small-cap biotech ETFs as the next investment bubble. A bit of Googling came to a
decent seekingalpha article that mentioned
XBI, BBH, and FBT. Apparently, the Chinese government's bought $96m worth of
Illumina genetic sequencing machines (@ $750k a pop) - the same machines used by personal genomics companies
23andme,
decodeme, and
counsyl. Will the new phrase be "cheap chinese genomes"?
Optimization efficacy of evolutionary techniques
Natural selection
- Slow!
- Optimized for selecting the best replicators
- Builds on previous adaptations (doesn't optimize best adaptations)
- Optimization principle: Just good enough - ie selected for whatever's just good enough to pass on genes, not for any longer (healthy life, etc.)
Human Intelligence
- Recombinant DNA technology - cut & paste via enzyme restriction endonuclease + ligase
- DNA printer - writes DNA
- http://www.bio-era.net/
Recursive AI
Protein folding
Game:
http://fold.it/portal/
http://online.wsj.com/article/SB124207326903607931.html
- Drug metabolism
- High-risk drugs
Edit, 04/25/2010 (DNA Day)
The new machine, the HiSeq2000, will begin shipping next month with a cost of $690,000 vs. $500,000 for Illumina's current model. It is being unveiled today at J.P. Morgan's investment conference in San Francisco. The Beijing Genomics Institute will be the first customer, purchasing 128 of the new machines.
Illumina's Cheap New Gene Machine
Matthew Herper, 01.12.10, 03:00 PM EST